Completed
The National Academies’ Forum on Neuroscience and Nervous Systems Disorders hosted a workshop on September 10, 2024, they brought together diverse perspectives to examine the promising but understudied applications of GLP-1R agonists in neurological and psychiatric disorders. Experts reviewed the current knowledge and research gaps about how GLP-1R agonists work and evidence of their clinical efficacy for neurodegenerative diseases, substance use disorders, and pain. Attendees from academia, industry, government, and nonprofits also explored regulatory challenges/opportunities in repurposing these drugs for brain conditions.
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.
Discover
Events
Convening Activities
Engage
Work with us